VOR Vor Biopharma Inc.
Fundamentals / CIK 0001817229 / USDVor Biopharma Inc. reported $496.3M in total assets and net income of $1.35B through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VOR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$177.4M Operating profit
-
Net Income FY 2025$1.35B GAAP bottom line
-
Diluted EPS FY 2025$22.69 Split-adjusted
-
Free Cash Flow FY 2025-$119.7M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$481.6M Total debt: $2.81M
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Research & Development | $321.5M | $93.31M | $94.31M | $64.55M | $47.53M | $31.62M |
| Total Operating Expenses | $371.6M | $121.2M | $126.0M | $93.42M | $69.02M | $43.37M |
| Operating Income | -$371.6M | -$121.2M | -$126.0M | -$93.42M | -$69.02M | -$43.37M |
| EBITDA | -$368.8M | -$117.7M | -$122.5M | -$90.89M | -$67.58M | -$42.76M |
| Interest Income | $5.87M | $4.27M | $8.17M | $1.32M | $119K | $29K |
| Net Income | -$696.0M | -$116.9M | -$117.9M | -$92.09M | -$68.90M | -$43.34M |
| Basic EPS | -$70.50 | -$34.03 | -$35.00 | -$46.60 | -$42.00 | -$4,611.40 |
| Diluted EPS | -$70.50 | -$34.03 | -$35.00 | -$46.60 | -$42.00 | -$4,611.40 |
| Basic Shares Outstanding | 9.9M | 3.4M | 3.4M | 2.0M | 1.7M | 10.7K |
| Diluted Shares Outstanding | 9.9M | 3.4M | 3.4M | 2.0M | 1.7M | 10.7K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $34.53M | $25.92M | $17.59M | $19.19M | $14.14M | $261.5M | $26.70M | $25.35M |
| Total Operating Expenses | $58.44M | $47.85M | $35.16M | $35.96M | $28.11M | $274.3M | $33.29M | $31.31M |
| Operating Income | -$58.44M | -$47.85M | -$35.16M | -$35.96M | -$28.11M | -$274.3M | -$33.29M | -$31.31M |
| EBITDA | -$58.41M | -$47.82M | -$35.13M | -$35.94M | -$26.01M | -$272.2M | -$32.47M | -$30.45M |
| Interest Income | $4.61M | $4.34M | $3.94M | $2.79M | $1.73M | $537K | $805K | $599K |
| Net Income | -$86.73M | -$62.81M | -$219.6M | $1.72B | -$812.7M | -$1.57B | -$32.49M | -$30.71M |
| Basic EPS | -$1.45 | -$1.16 | -$5.11 | -- | -$121.63 | -$251.24 | -$5.21 | -- |
| Diluted EPS | -$1.45 | -$1.16 | -$5.11 | -- | -$121.63 | -$251.24 | -$5.21 | -- |
| Basic Shares Outstanding | 59.7M | 54.3M | 43.0M | -- | 6.7M | 6.3M | 6.2M | -- |
| Diluted Shares Outstanding | 59.7M | 54.3M | 43.0M | -- | 6.7M | 6.3M | 6.2M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $396.5M | $81.95M | $31.36M | $57.71M | $119.8M | $48.54M |
| Short-Term Investments | $58.72M | $9.98M | $105.8M | $172.5M | $87.67M | $0 |
| Cash & Short-Term Investments | $455.2M | $91.90M | $137.2M | $230.2M | $207.5M | $48.54M |
| Other Current Assets | $1.75M | $380K | $475K | $2.34M | $2.09M | $100K |
| Total Current Assets | $458.1M | $96.51M | $140.8M | $236.9M | $214.4M | $49.11M |
| Property, Plant & Equipment, Net | $533K | $6.58M | $10.05M | $12.63M | $6.85M | $4.73M |
| Other Non-Current Assets | $2.38M | $2.38M | $4.81M | $2.92M | $3.25M | $3.40M |
| Total Non-Current Assets | $6.02M | $46.38M | $57.32M | $62.42M | $28.19M | $26.80M |
| Total Assets | $464.1M | $142.9M | $198.1M | $299.4M | $242.6M | $75.91M |
| Accounts Payable | $5.13M | $1.50M | $815K | $1.77M | $1.54M | $2.36M |
| Other Current Liabilities | -- | $0 | $50K | $186K | $434K | $723K |
| Total Current Liabilities | $25.17M | $18.61M | $15.57M | $13.12M | $10.15M | $10.21M |
| Total Non-Current Liabilities | $603.3M | $27.61M | $31.83M | $35.64M | $16.17M | $17.43M |
| Total Liabilities | $628.4M | $46.23M | $47.40M | $48.76M | $26.33M | $27.64M |
| Total Debt (incl. Leases) | $3.00M | $31.83M | $35.66M | $38.91M | $18.01M | $18.29M |
| Common Stock | $18K | $13K | $7.0K | $7.0K | $4.0K | $1.0K |
| Retained Earnings | -$1.15B | -$457.0M | -$340.1M | -$222.2M | -$130.1M | -$61.22M |
| Accumulated Other Comp. Income | $41K | $22K | -$77K | -$770K | -- | -- |
| Total Stockholders' Equity | -$164.3M | $96.66M | $150.7M | $250.6M | $216.3M | -$59.06M |
| Total Equity | -$164.3M | $96.66M | $150.7M | $250.6M | $216.3M | -$59.06M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $78.98M | $107.9M | $169.9M | $396.5M | $160.5M | $190.6M | $50.05M | $81.95M |
| Short-Term Investments | $402.6M | $358.3M | $321.7M | $58.72M | $10.00M | $9.99M | $9.99M | $9.98M |
| Cash & Short-Term Investments | $481.6M | $466.1M | $491.5M | $455.2M | $170.5M | $200.6M | $60.00M | $91.90M |
| Other Current Assets | $4.00M | $3.10M | $2.86M | $1.75M | $1.28M | $449K | $297K | $380K |
| Total Current Assets | $490.5M | $475.1M | $500.8M | $458.1M | $172.5M | $204.9M | $64.85M | $96.51M |
| Property, Plant & Equipment, Net | $623K | $648K | $565K | $533K | $271K | $0 | $5.99M | $6.58M |
| Other Non-Current Assets | $2.39M | $2.41M | $2.41M | $2.38M | $269K | $420K | $2.37M | $2.38M |
| Total Non-Current Assets | $5.79M | $5.95M | $5.97M | $6.02M | $3.75M | $444K | $44.47M | $46.38M |
| Total Assets | $496.3M | $481.1M | $506.7M | $464.1M | $176.2M | $205.4M | $109.3M | $142.9M |
| Accounts Payable | $5.61M | $4.00M | $1.04M | $5.13M | $885K | $669K | $3.73M | $1.50M |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | $44K | $0 |
| Total Current Liabilities | $36.34M | $24.81M | $16.08M | $25.17M | $18.84M | $58.77M | $16.73M | $18.61M |
| Total Non-Current Liabilities | $597.1M | $656.4M | $641.1M | $603.3M | $2.38B | $1.65B | $26.52M | $27.61M |
| Total Liabilities | $633.5M | $681.2M | $657.2M | $628.4M | $2.40B | $1.71B | $43.24M | $46.23M |
| Total Debt (incl. Leases) | $2.81M | $2.88M | $2.94M | $3.00M | $3.06M | -- | $30.78M | $31.83M |
| Common Stock | $20K | $19K | $19K | $18K | $15K | $13K | $13K | $13K |
| Retained Earnings | -$1.52B | -$1.44B | -$1.37B | -$1.15B | -$2.88B | -$2.06B | -$489.5M | -$457.0M |
| Accumulated Other Comp. Income | -$1.84M | -$922K | -$706K | $41K | $12K | $14K | $23K | $22K |
| Total Stockholders' Equity | -$137.2M | -$200.2M | -$150.4M | -$164.3M | -$2.23B | -$1.51B | $66.07M | $96.66M |
| Total Equity | -$137.2M | -$200.2M | -$150.4M | -$164.3M | -$2.23B | -$1.51B | $66.07M | $96.66M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$696.0M | -$116.9M | -$117.9M | -$92.09M | -$68.90M | -$43.34M |
| Depreciation & Amortization | $2.89M | $3.53M | $3.49M | $2.52M | $1.43M | $605K |
| Stock-Based Compensation | $18.91M | $9.85M | $13.36M | $10.70M | $4.32M | $1.34M |
| Operating Cash Flow | -$142.7M | -$99.66M | -$100.3M | -$85.14M | -$69.14M | -$36.29M |
| Capital Expenditure | -$941K | -$229K | -$1.07M | -$8.46M | -$3.89M | -$4.16M |
| Free Cash Flow | -$143.7M | -$99.89M | -$101.4M | -$93.61M | -$73.04M | -$40.45M |
| Purchases of Investments | -$53.66M | -$9.91M | -$74.92M | -$123.2M | -$87.76M | -- |
| Investing Cash Flow | -$48.80M | $96.86M | $71.01M | -$94.09M | -$91.65M | -$4.16M |
| Common Stock Issued | $70.11M | $275K | $4.58M | $4.45M | -- | -- |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $503.8M | $53.39M | $2.94M | $117.1M | $232.9M | $82.53M |
| Net Change in Cash | $312.3M | $50.59M | -$26.35M | -$62.09M | $72.12M | $42.07M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$86.73M | -$62.81M | -$219.6M | $1.72B | -$812.7M | -$1.57B | -$32.49M | -$30.71M |
| Depreciation & Amortization | $39K | $36K | $28K | $23K | $2.10M | $2.10M | $825K | $865K |
| Stock-Based Compensation | $9.94M | $9.40M | $8.87M | $7.11M | $8.03M | $1.84M | $1.93M | $1.71M |
| Operating Cash Flow | -$32.75M | -$25.38M | -$38.25M | -$22.80M | -$53.66M | -$35.18M | -$31.07M | -$24.06M |
| Capital Expenditure | -$25K | -$120K | -$48K | -$314K | -$244K | -$152K | -$231K | -$72K |
| Free Cash Flow | -$32.77M | -$25.50M | -$38.29M | -$23.11M | -$53.91M | -$35.34M | -$31.30M | -$24.14M |
| Purchases of Investments | -$117.2M | -$79.00M | -$276.5M | -$53.66M | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$44.78M | -$36.53M | -$263.2M | -$48.97M | -$244K | $646K | -$230K | -$72K |
| Common Stock Issued | -- | -- | -- | $49.85M | $20.26M | $0 | $0 | -$22K |
| Financing Cash Flow | $48.65M | -$106K | $74.87M | $307.8M | $21.55M | $175.1M | -$606K | $53.29M |
| Net Change in Cash | -$28.88M | -$62.02M | -$226.6M | $236.0M | -$32.36M | $140.5M | -$31.90M | $29.15M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -- | -120.9% | -78.2% | -36.7% | -31.9% | -- |
| Return on Assets (ROA) | -150.0% | -81.8% | -59.5% | -30.8% | -28.4% | -57.1% |
| Current Ratio | 18.20x | 5.19x | 9.04x | 18.06x | 21.12x | 4.81x |
| Quick Ratio | 18.08x | 4.94x | 8.81x | 17.55x | 20.43x | 4.76x |
| Debt to Equity | -- | 0.33x | 0.24x | 0.16x | 0.08x | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -179.5% | -120.9% |
| Return on Assets (ROA) | 272.8% | 130.5% | -174.3% | -150.0% | -1389.9% | -810.4% | -108.5% | -81.8% |
| Current Ratio | 13.50x | 19.15x | 31.15x | 18.20x | 9.16x | 3.49x | 3.88x | 5.19x |
| Quick Ratio | 13.25x | 18.78x | 30.57x | 18.08x | 9.05x | 3.41x | 3.59x | 4.94x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | 0.47x | 0.33x |